OBJECTIVE: CD40-CD40 ligand (CDL40L) interaction is essential for the T-lym
phocyte-dependent immune response. This interaction may be operational in t
he pathogenesis of inflammatory bowel diseases (IBD). The present study exa
mined the expression of CD40 in peripheral blood mononuclear cells (PBMNCs)
and tissue specimens, and CD40-stimulated interleukin (IL)-12 release from
PBMNCs in IBD.
METHODS: The expression of CD40 in PBMNCs End tissue inflammatory cells was
examined by flowcytometry and immunohistochemistry, respectively. IL-12 re
lease was measured in cultured media of PBMNCs by an enzyme-linked immunoso
rbent assay.
RESULTS: Most peripheral blood B-lymphocytes expressed CD40 in all subjects
. However, in ulcerative colitis (UC) patients, a significantly increased m
ean fluorescence intensity (MFI) of CD40 on B-lymphocytes was detected, com
pared with control subjects and patients with Crohn's disease (CD). In cont
rast, both the percentage positivity and MFI of CD40 on monocytes of active
CD subjects were significantly increased, compared with the other groups.
In active CD patients, a high level of IL-12 release from PBMNCs was observ
ed by CD40 stimulation, compared with those of the other groups. When prime
d with IFN-gamma, PBMNCs from inactive CD patients released a significantly
high level of IL-12, probably via stimulation by the CD40 monoclonal antib
ody. In the affected mucosa of CD, numerous CD40-positive cells were demons
trated, and they were also CD68-positive, suggesting these double CD40/CD68
-positive cells are tissue macrophages.
CONCLUSIONS: These results suggest that the examination of CD40 expression
in PBMNCs might enable the differentiation of CD from UC. CD40-high monocyt
es in CD patients may play a role in the pathogenesis of CD. (Am J Gastroen
terol 2000;95:1516-1523. (C) 2000 by Am. Coll. of Gastroenterology).